InfuSystem (NYSEAMERICAN:INFU) Rating Increased to Strong-Buy at StockNews.com

InfuSystem (NYSEAMERICAN:INFU) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Tuesday.

InfuSystem Trading Down 2.1 %

Shares of NYSEAMERICAN:INFU opened at $7.94 on Tuesday. InfuSystem has a 52-week low of $7.40 and a 52-week high of $11.44. The company has a quick ratio of 1.54, a current ratio of 1.95 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $168.80 million, a P/E ratio of 264.75 and a beta of 1.30.

Institutional Investors Weigh In On InfuSystem

Institutional investors and hedge funds have recently bought and sold shares of the business. WINTON GROUP Ltd bought a new position in InfuSystem during the 3rd quarter valued at approximately $101,000. Citigroup Inc. raised its position in InfuSystem by 124.1% in the 3rd quarter. Citigroup Inc. now owns 50,640 shares of the medical instruments supplier’s stock worth $488,000 after buying an additional 28,038 shares during the last quarter. First Eagle Investment Management LLC boosted its holdings in shares of InfuSystem by 29.6% during the 3rd quarter. First Eagle Investment Management LLC now owns 468,400 shares of the medical instruments supplier’s stock valued at $4,515,000 after acquiring an additional 107,001 shares during the last quarter. Heartland Advisors Inc. grew its stake in shares of InfuSystem by 17.6% in the third quarter. Heartland Advisors Inc. now owns 500,000 shares of the medical instruments supplier’s stock worth $4,820,000 after acquiring an additional 75,000 shares during the period. Finally, Ranger Investment Management L.P. raised its holdings in shares of InfuSystem by 4.7% during the fourth quarter. Ranger Investment Management L.P. now owns 689,842 shares of the medical instruments supplier’s stock valued at $7,271,000 after purchasing an additional 30,835 shares during the last quarter. Hedge funds and other institutional investors own 71.13% of the company’s stock.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.